Wijsenbeek MS - Search Results

1

Patient reported side-effects of prednisone and methotrexate in a real-world sarcoidosis population.

Kahlmann V, Moor CC, Veltkamp M, Wijsenbeek MS. Kahlmann V, et al. Among authors: wijsenbeek ms. Chron Respir Dis. 2021 Jan-Dec;18:14799731211031935. doi: 10.1177/14799731211031935. Chron Respir Dis. 2021. PMID: 34569301 Free PMC article.

2

Treatment of Sarcoidosis.

Wijsenbeek MS, Culver DA. Wijsenbeek MS, et al. Clin Chest Med. 2015 Dec;36(4):751-67. doi: 10.1016/j.ccm.2015.08.015. Clin Chest Med. 2015. PMID: 26593147 Review.

3

No evidence found for an association between prednisone dose and FVC change in newly-treated pulmonary sarcoidosis.

Broos CE, Poell LHC, Looman CWN, In 't Veen JCCM, Grootenboers MJJH, Heller R, van den Toorn LM, Wapenaar M, Hoogsteden HC, Kool M, Wijsenbeek MS, van den Blink B. Broos CE, et al. Among authors: wijsenbeek ms. Respir Med. 2018 May;138S:S31-S37. doi: 10.1016/j.rmed.2017.10.022. Epub 2017 Oct 31. Respir Med. 2018. PMID: 29137908 Free article.

4

Clubbing in patients with fibrotic interstitial lung diseases.

van Manen MJG, Vermeer LC, Moor CC, Vrijenhoeff R, Grutters JC, Veltkamp M, Wijsenbeek MS. van Manen MJG, et al. Among authors: wijsenbeek ms. Respir Med. 2017 Nov;132:226-231. doi: 10.1016/j.rmed.2017.10.021. Epub 2017 Nov 2. Respir Med. 2017. PMID: 29229102 Free article.

5

Integrating Patient Perspectives into Personalized Medicine in Idiopathic Pulmonary Fibrosis.

Moor CC, Heukels P, Kool M, Wijsenbeek MS. Moor CC, et al. Among authors: wijsenbeek ms. Front Med (Lausanne). 2017 Dec 20;4:226. doi: 10.3389/fmed.2017.00226. eCollection 2017. Front Med (Lausanne). 2017. PMID: 29326935 Free PMC article. Review.

6

Development and feasibility of an eHealth tool for idiopathic pulmonary fibrosis.

Moor CC, van Manen MJG, Tak NC, van Noort E, Wijsenbeek MS. Moor CC, et al. Among authors: wijsenbeek ms. Eur Respir J. 2018 Mar 29;51(3):1702508. doi: 10.1183/13993003.02508-2017. Print 2018 Mar. Eur Respir J. 2018. PMID: 29348156 Free article. No abstract available.

7

A home monitoring program including real-time wireless home spirometry in idiopathic pulmonary fibrosis: a pilot study on experiences and barriers.

Moor CC, Wapenaar M, Miedema JR, Geelhoed JJM, Chandoesing PP, Wijsenbeek MS. Moor CC, et al. Among authors: wijsenbeek ms. Respir Res. 2018 May 29;19(1):105. doi: 10.1186/s12931-018-0810-3. Respir Res. 2018. PMID: 29843728 Free PMC article.

8

Needs, Perceptions and Education in Sarcoidosis: A Live Interactive Survey of Patients and Partners.

Moor CC, van Manen MJG, van Hagen PM, Miedema JR, van den Toorn LM, Gür-Demirel Y, Berendse APC, van Laar JAM, Wijsenbeek MS. Moor CC, et al. Among authors: wijsenbeek ms. Lung. 2018 Oct;196(5):569-575. doi: 10.1007/s00408-018-0144-4. Epub 2018 Aug 7. Lung. 2018. PMID: 30088094 Free PMC article.

9

Design of a Study Assessing Disease Behaviour During the Peri-Diagnostic Period in Patients with Interstitial Lung Disease: The STARLINER Study.

Wijsenbeek M, Bendstrup E, Valenzuela C, Henry MT, Moor C, Bengus M, Perjesi A, Gilberg F, Kirchgaessler KU, Vancheri C. Wijsenbeek M, et al. Adv Ther. 2019 Jan;36(1):232-243. doi: 10.1007/s12325-018-0845-3. Epub 2018 Nov 30. Adv Ther. 2019. PMID: 30506309 Free PMC article.

10

Inflammation and immunity in IPF pathogenesis and treatment.

Heukels P, Moor CC, von der Thüsen JH, Wijsenbeek MS, Kool M. Heukels P, et al. Among authors: wijsenbeek ms. Respir Med. 2019 Feb;147:79-91. doi: 10.1016/j.rmed.2018.12.015. Epub 2019 Jan 9. Respir Med. 2019. PMID: 30704705 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

183 results

Search Page